Literature DB >> 30760532

Streptococcus agalactiae Strains with Chromosomal Deletions Evade Detection with Molecular Methods.

Isabella A Tickler1, Fred C Tenover2,3, Scott Dewell2, Victoria M Le2, Rachel N Blackman2, Richard V Goering4, Amy E Rogers5, Heather Piwonka6, Brittney D Jung-Hynes7, Derrick J Chen7, Michael J Loeffelholz2,8, Devasena Gnanashanmugam2, Ellen Jo Baron2,3.   

Abstract

Surveillance of circulating microbial populations is critical for monitoring the performance of a molecular diagnostic test. In this study, we characterized 31 isolates of Streptococcus agalactiae (group B Streptococcus [GBS]) from several geographic locations in the United States and Ireland that contain deletions in or adjacent to the region of the chromosome that encodes the hemolysin gene cfb, the region targeted by the Xpert GBS and GBS LB assays. PCR-negative, culture-positive isolates were recognized during verification studies of the Xpert GBS assay in 12 laboratories between 2012 and 2018. Whole-genome sequencing of 15 GBS isolates from 11 laboratories revealed four unique deletions of chromosomal DNA ranging from 181 bp to 49 kb. Prospective surveillance studies demonstrated that the prevalence of GBS isolates containing deletions in the convenience sample was <1% in three geographic locations but 7% in a fourth location. Among the 15 isolates with chromosomal deletions, multiple pulsed-field gel electrophoresis types were identified, one of which appears to be broadly dispersed across the United States.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Streptococcus agalactiaezzm321990; group B streptococcus; whole-genome sequencing

Mesh:

Substances:

Year:  2019        PMID: 30760532      PMCID: PMC6440789          DOI: 10.1128/JCM.02040-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  34 in total

Review 1.  Pulsed field gel electrophoresis: a review of application and interpretation in the molecular epidemiology of infectious disease.

Authors:  Richard V Goering
Journal:  Infect Genet Evol       Date:  2010-08-06       Impact factor: 3.342

2.  Antepartum screening for group B Streptococcus by three FDA-cleared molecular tests and effect of shortened enrichment culture on molecular detection rates.

Authors:  Brianne A Couturier; Trent Weight; Haley Elmer; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

3.  Comparison of the AmpliVue, BD Max System, and illumigene Molecular Assays for Detection of Group B Streptococcus in Antenatal Screening Specimens.

Authors:  Shelley A Miller; Eszter Deak; Romney Humphries
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

4.  A Nonhemolytic Group B Streptococcus Strain Exhibits Hypervirulence.

Authors:  Claire Gendrin; Jay Vornhagen; Blair Armistead; Pallavi Singh; Christopher Whidbey; Sean Merillat; David Knupp; Robert Parker; Lisa M Rogers; Phoenicia Quach; Lakshminarayan M Iyer; L Aravind; Shannon D Manning; David M Aronoff; Lakshmi Rajagopal
Journal:  J Infect Dis       Date:  2018-03-05       Impact factor: 5.226

Review 5.  Group B streptococcal disease in infants: progress in prevention and continued challenges.

Authors:  Jennifer R Verani; Stephanie J Schrag
Journal:  Clin Perinatol       Date:  2010-06       Impact factor: 3.430

Review 6.  Reliable Detection of Group B Streptococcus in the Clinical Laboratory.

Authors:  Manuel Rosa-Fraile; Barbara Spellerberg
Journal:  J Clin Microbiol       Date:  2017-06-28       Impact factor: 5.948

7.  Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease.

Authors:  Feng-Ying C Lin; Leonard E Weisman; Parvin Azimi; Amy E Young; Kathleen Chang; Mikhaela Cielo; Patricia Moyer; James F Troendle; Rachel Schneerson; John B Robbins
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

8.  Copy number variant detection in inbred strains from short read sequence data.

Authors:  Jared T Simpson; Rebecca E McIntyre; David J Adams; Richard Durbin
Journal:  Bioinformatics       Date:  2009-12-18       Impact factor: 6.937

9.  Detection of Group B Streptococcus Directly from Collected ESwab Samples by Use of the BD Max GBS Assay.

Authors:  Suzane Silbert; Talita T Rocchetti; Alicia Gostnell; Carly Kubasek; Raymond Widen
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  5 in total

1.  Biographical Feature: Fred C. Tenover, Ph.D., D(ABMM), F(AAM), FIDSA.

Authors:  Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

Review 2.  Group B Streptococcal Neonatal Meningitis.

Authors:  Teresa Tavares; Liliana Pinho; Elva Bonifácio Andrade
Journal:  Clin Microbiol Rev       Date:  2022-02-16       Impact factor: 50.129

3.  Comparative study of Revogene GBS LB assay and GeneXpert GBS LB assay for the detection of group B Streptococcus in prenatal screening samples.

Authors:  Tsokyi Choera; Brittney Jung-Hynes; Derrick J Chen
Journal:  BMC Infect Dis       Date:  2020-01-14       Impact factor: 3.090

4.  Visual multiple cross displacement amplification for the rapid identification of S. agalactiae immediately from vaginal and rectal swabs.

Authors:  Xueqin Cheng; Zhiqian Dou; Jing Yang; Dexi Liu; Yulong Gu; Fenglin Cai; Xiaobing Li; Meifang Wang; Yijun Tang
Journal:  AMB Express       Date:  2021-01-06       Impact factor: 3.298

5.  Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae.

Authors:  Meng-Yi Han; Chen Xie; Qing-Qing Huang; Qiao-Hua Wu; Qing-Yun Deng; Tian-Ao Xie; Ye-Ling Liu; Zhuo-Lei Li; Jing-Hua Zhong; Yan-Chao Wang; Xu-Guang Guo
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-09-06       Impact factor: 3.944

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.